Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3299 (-0.66%) ($0.3299 - $0.3299) on Thu. May. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.62% (three month average) | RSI | 36 | Latest Price | $0.3299(-0.66%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -8.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLK(93%) IVE(86%) REMX(83%) EWP(77%) QQQ(73%) | Factors Impacting ANPC price | ANPC will decline at least -5.31% in a week (0% probabilities). SHY(-47%) BND(-35%) VCSH(-33%) BNDX(-33%) VCIT(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.31% (StdDev 10.62%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.38 | 5 Day Moving Average | $0.35(-5.74%) | 10 Day Moving Average | $0.33(-0.03%) | 20 Day Moving Average | $0.38(-13.18%) | To recent high | -63.8% | To recent low | 15.8% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |